Vanda Pharmaceuticals (VNDA) Revenue (2010 - 2026)
Vanda Pharmaceuticals' Revenue came in at $50.53 million for Q2 2026, down 3.9% from $52.59 million a year earlier and down 2.3% from the prior quarter.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Revenue (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Vanda Pharmaceuticals reported Revenue of $215.72 million, up 6.0% year-over-year; for FY2025, it was $216.11 million, up 8.7% from FY2024.
- Revenue carries a five-year compound annual growth rate of -2.7% (FY2020 to FY2025).
- Going back by year, Revenue was $198.77 million in FY2024 (+3.2%), $192.64 million in FY2023 (-24.3%), $254.38 million in FY2022 (-5.3%) and $268.68 million in FY2021 (+8.3%).
- The Q2 2026 figure represents the lowest quarterly Revenue since Q1 2025.
- Year-over-year, Revenue increased in seven of the last eight quarters, with growth averaging 9.4%.
- The fastest year-over-year change in Revenue over five years came in Q3 2024 (growth of 22.8%), and the weakest in Q3 2023 (a decline of 40.6%).
- Business Quant data shows VNDA's Revenue at $51.72 million (Q1 2026), $57.22 million (Q4 2025) and $56.26 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Vanda Pharmaceuticals | 279.91 Mn | -650.03 Mn | 46.97 Mn | 50.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.53 Mn |
| Mar 31, 2026 | 51.72 Mn |
| Dec 31, 2025 | 57.22 Mn |
| Sep 30, 2025 | 56.26 Mn |
| Jun 30, 2025 | 52.59 Mn |
| Mar 31, 2025 | 50.04 Mn |
| Dec 31, 2024 | 53.19 Mn |
| Sep 30, 2024 | 47.65 Mn |
| Jun 30, 2024 | 50.47 Mn |
| Mar 31, 2024 | 47.46 Mn |
| Dec 31, 2023 | 45.27 Mn |
| Sep 30, 2023 | 38.82 Mn |
| Jun 30, 2023 | 46.06 Mn |
| Mar 31, 2023 | 62.50 Mn |
| Dec 31, 2022 | 64.48 Mn |
| Sep 30, 2022 | 65.32 Mn |
| Jun 30, 2022 | 64.39 Mn |
| Mar 31, 2022 | 60.19 Mn |
| Dec 31, 2021 | 68.02 Mn |
| Sep 30, 2021 | 70.10 Mn |
API Access
Vanda Pharmaceuticals Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=VNDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();